Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105669732B reveals a scalable 3-step synthesis for Anacetrapib intermediates. Discover cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107417613A reveals copper-catalyzed route. High yield, mild conditions. Ideal for pharma intermediate supply chain optimization and cost reduction.
Patent CN106749027A reveals improved yield and reduced waste for dexmedetomidine intermediate manufacturing supply chain.
Novel patent CN120040456A details green synthesis of sitagliptin phosphate offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN109957585B reveals a high-efficiency ketoreductase process for chiral alcohol intermediates, offering significant cost reduction and scalable supply chain solutions.
Discover a novel phthalide preparation method avoiding high-pressure hydrogenation. Ideal for agrochemical intermediates like kresoxim-methyl with reduced costs.
Patent CN113549102B reveals a thiourea-free ozone/CO method for removing p-methoxyphenyl groups, offering high purity and reduced sulfur waste for API manufacturing.
Novel glycine-based synthetic route for Tigecycline API ensures high purity and reduced impurities for reliable pharmaceutical supply chains and cost efficiency.
Patent CN103773724B reveals biocatalytic route for high-purity chiral alcohol. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN105348250A reveals novel lipid-lowering compound synthesis. Discover cost-effective manufacturing and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN115093313A discloses high-enantioselectivity rhodium catalysts for C-H activation, offering scalable routes for pharmaceutical intermediates.
Patent CN102876759A details a chemo-enzymatic NAD preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107056756B reveals a method achieving 98.4% purity using cyclic amine catalysts, offering significant cost reduction and scalability for API manufacturing.
Patent CN101573330A reveals a novel stereo-selective route for trans-[18F]-FACBC precursors, offering significant cost reduction in PET tracer manufacturing and supply chain reliability.
Patent CN101993468A details a high-yield synthesis of dienogest intermediates. Discover cost-effective manufacturing strategies and supply chain advantages for hormonal APIs.
Patent CN118638091A details a novel synthesis for oxabenzo[3.2.2] skeletons, offering cost reduction and scalable manufacturing for high-purity pharmaceutical intermediates.
Advanced rhodium-catalyzed synthesis of gem-difluorocyclopentane intermediates offers high yield and scalability for pharmaceutical manufacturing supply chains.
Patent CN105198863B reveals a novel crystallization method for Losartan, achieving 99.5% purity without salt conversion, offering significant cost reduction in API manufacturing.
Patent CN101090770B discloses a dual-ligand Rh-catalyzed system for asymmetric hydrogenation, delivering superior enantioselectivity and cost efficiency for API manufacturing.
Patent CN117164599A reveals a continuous three-step method for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for ADC drug production.